(MT Newswires) -- Walmart (WMT) says it's already seeing an impact on shopping demand from people taking the diabetes drug Ozempic, Wegovy and other appetite-suppressing medications. David Ingles and Yvonne man have more on Bloomberg Television.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.42 USD | +0.41% | +9.24% | +24.38% |
03:20pm | Target, Walmart shoppers seek home goods, grocery delivery online | RE |
03:07pm | Walmart Adds Pawp Veterinary Consulting Services to Walmart+ Memberships | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.38% | 525B | |
+17.22% | 38.73B | |
+3.16% | 37.51B | |
+20.80% | 34.91B | |
+13.20% | 30.34B | |
+7.37% | 27.57B | |
-15.78% | 25.59B | |
+16.07% | 18.73B | |
+5.87% | 17.95B | |
+5.80% | 14.65B |
- Stock Market
- Equities
- WMT Stock
- News Walmart Inc.
- Walmart Says Ozempic Causing 'Slight Pullback' by Shoppers